During the past decade, Charite CCM Neurologie Berlin conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 5 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charite CCM Neurologie Berlin" #1 sponsor was "Charite University, Berlin, Germany" with 15 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "Theravance Biopharma" with 3 trials sponsored, "German Parkinson Study Group (GPS)" with 2 trials sponsored and "University of Magdeburg" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charite CCM Neurologie Berlin" #1 collaborator was "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Competence Network on Parkinson's Disease" with 2 trials as a collaborator, "EBS Technologies GmbH" with 2 trials as a collaborator, "German Federal Ministry of Education and Research" with 2 trials as a collaborator and "Medtronic" with 2 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Charite CCM Neurologie Berlin" are "Symptomatic Neurogenic Orthostatic Hypotension" (3 trials), "Healthy Subjects" (2 trials), "Mild Cognitive Impairment, So Stated" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials) and "Parkinson's Disease" (2 trials). Many other conditions were trialed in "Charite CCM Neurologie Berlin" in a lesser frequency.

Most popular intervention types in "Charite CCM Neurologie Berlin" are "Device" (15 trials), "Drug" (8 trials), "Behavioral" (4 trials), "Biological" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Ocrelizumab" (3 trials), "SHAM" (3 trials), "ampreloxetine" (3 trials) and "brain stimulation" (3 trials). Other intervention names were less common.

The vast majority of trials in "Charite CCM Neurologie Berlin" are 30 trials for "All" genders.

Currently, there are NaN active trials in "Charite CCM Neurologie Berlin". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Charite CCM Neurologie Berlin, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Charite CCM Neurologie Berlin, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".